Most importantly, there is growing evidence of an inflammatory response in the blood of DLB patients, such as elevated expression of chronic inflammatory factors such as Tumor Necrosis Factor-α (TNF-α), Interleukin-1β (IL-1β), and Interleukin-6 (IL-6) compared to controls [63]. The gene discussed is IL1B; the disease is Lewy body dementia.